Lawrence Tim Goodnough

Professional Education

Board Certification: Blood Banking/Transfusion Medicine, American Board of Pathology (1987)

Fellowship: Case Western Reserve University School of Medicine (1981) OH

Residency: University of Alabama Hospital (1978) AL

Medical Education: University of Pennsylvania (1975) PA

Board Certification: Medical Oncology, American Board of Internal Medicine (1981)

Board Certification: Internal Medicine, American Board of Internal Medicine (1978)

Board Certification: Hematology, American Board of Internal Medicine (1980)

Internship: University of Alabama Hospital (1976) AL

Administrative Appointments

Director, Transfusion Service Stanford Medical Center, 2004

Associate Director, Stanford Blood Center, 2004

Chair, School of Medicine Faculty Senate Steering Committee, 2008

Member, Committee on Admissions, Stanford University School of Medicine, 2008

Open aortic valve replacement in a patient with Glanzmann's thrombasthenia: a multidisciplinary strategy to minimize perioperative bleeding.
Sheikh, A. Y., Hill, C. C., Goodnough, L. T., Leung, L. L., & Fischbein, M. P. (2014). Open aortic valve replacement in a patient with Glanzmann's thrombasthenia: a multidisciplinary strategy to minimize perioperative bleeding. Transfusion, 54(2), 300-305.

Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion
Uhlmann, E. J., Shenoy, S., & Goodnough, L. T. (2014). Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion. TRANSFUSION, 54(2), 384-388.

Concepts of blood transfusion in adults.
Goodnough, L. T., Levy, J. H., & Murphy, M. F. (2013). Concepts of blood transfusion in adults. Lancet, 381(9880), 1845-1854.

Blood management: transfusion medicine comes of age.
Goodnough, L. T. (2013). Blood management: transfusion medicine comes of age. Lancet, 381(9880), 1791-1792.

Logistics of transfusion support for patients with massive hemorrhage
Goodnough, L. T., Spain, D. A., & Maggio, P. (2013). Logistics of transfusion support for patients with massive hemorrhage. CURRENT OPINION IN ANESTHESIOLOGY, 26(2), 208-214.

Transfusion outcomes in patients undergoing coronary artery bypass grafting treated with prasugrel or clopidogrel: TRITON-TIMI 38 retrospective data analysis
Goodnough, L. T., Smith, P. K., Levy, J. H., Poston, R. S., Short, M. A., & LeNarz, Lr. A. (2013). Transfusion outcomes in patients undergoing coronary artery bypass grafting treated with prasugrel or clopidogrel: TRITON-TIMI 38 retrospective data analysis. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 145(4), 1077-?.

Update on erythropoiesis-stimulating agents.
Goodnough, L. T., & Shander, A. (2013). Update on erythropoiesis-stimulating agents. Best practice & research. Clinical anaesthesiology, 27(1), 121-129.

In reply.
Goodnough, L. T., & Shander, A. (2013). In reply. Anesthesiology, 118(1), 223-224.

Blood ordering from the operating room: turnaround time as a quality indicator
McClain, C. M., Hughes, J., Andrews, J. C., Blackburn, J., Sephel, S., & Young, P. P. (2013). Blood ordering from the operating room: turnaround time as a quality indicator. TRANSFUSION, 53(1), 41-48.

Current Status of Pharmacologic Therapies in Patient Blood Management
Goodnough, L. T., & Shander, A. (2013). Current Status of Pharmacologic Therapies in Patient Blood Management. ANESTHESIA AND ANALGESIA, 116(1), 15-34.

A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
Onken, J. E., Bregman, D. B., Harrington, R. A., Morris, D., Acs, P., & Goodnough, L. T. (2013). A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Transfusion.

How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis products
Fontaine, M. J., Mills, A. M., Weiss, S., Hong, W.-J., Viele, M., & Goodnough, L. T. (2012). How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis products. TRANSFUSION, 52(10), 2081-2085.

Invited commentary.
Goodnough, L. T., & Levy, J. H. (2012). Invited commentary. Annals of thoracic surgery, 94(3), 709-?.

Operational, Quality, and Risk Management in the Transfusion Service: Lessons Learned
Goodnough, L. T. (2012). Operational, Quality, and Risk Management in the Transfusion Service: Lessons Learned. TRANSFUSION MEDICINE REVIEWS, 26(3), 252-261.

Iron deficiency syndromes and iron-restricted erythropoiesis (CME)
Goodnough, L. T. (2012). Iron deficiency syndromes and iron-restricted erythropoiesis (CME). TRANSFUSION, 52(7), 1584-1592.

Postpartum hemorrhage treated with a massive transfusion protocol at a tertiary obstetric center: a retrospective study
Gutierrez, M. C., GOODNOUGH, L. T., Druzin, M., & Butwick, A. J. (2012). Postpartum hemorrhage treated with a massive transfusion protocol at a tertiary obstetric center: a retrospective study. INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA, 21(3), 230-235.

A Reappraisal of Plasma, Prothrombin Complex Concentrates, and Recombinant Factor VIIa in Patient Blood Management
Goodnough, L. T. (2012). A Reappraisal of Plasma, Prothrombin Complex Concentrates, and Recombinant Factor VIIa in Patient Blood Management. CRITICAL CARE CLINICS, 28(3), 413-?.

Patient Blood Management
Goodnough, L. T., & Shander, A. (2012). Patient Blood Management. ANESTHESIOLOGY, 116(6), 1367-1376.

Use of point-of-care testing for plasma therapy
Goodnough, L. T., & Hill, C. C. (2012). Use of point-of-care testing for plasma therapy. TRANSFUSION, 52, 56S-64S.

A novel allocation strategy for blood transfusions: investigating the tradeoff between the age and availability of transfused blood
Atkinson, M. P., Fontaine, M. J., Goodnough, L. T., & Wein, L. M. (2012). A novel allocation strategy for blood transfusions: investigating the tradeoff between the age and availability of transfused blood. TRANSFUSION, 52(1), 108-117.

How we treat: transfusion medicine support of obstetric services
Goodnough, L. T., Daniels, K., Wong, A. E., Viele, M., Fontaine, M. F., & Butwick, A. J. (2011). How we treat: transfusion medicine support of obstetric services. TRANSFUSION, 51(12), 2540-2548.

Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients
Fontaine, M. J., Kuo, J., Chen, G., Galel, S. A., Miller, E., & Tyan, D. B. (2011). Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients. TRANSFUSION, 51(12), 2611-2618.

How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage
Goodnough, L. T., & Shander, A. (2011). How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage. BLOOD, 117(23), 6091-6099.

Quality management in the transfusion service: case studies in process improvement
Goodnough, L. T., Viele, M., Fontaine, M., Chua, L., Ferrer, Z., & Arber, D. A. (2011). Quality management in the transfusion service: case studies in process improvement. TRANSFUSION, 51(3), 600-609.

Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines
Goodnough, L. T., Maniatis, A., Earnshaw, P., Benoni, G., Beris, P., & Szpalski, M. (2011). Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. BRITISH JOURNAL OF ANAESTHESIA, 106(1), 13-22.

Detection, evaluation, and management of iron-restricted erythropoiesis
Goodnough, L. T., Nemeth, E., & Ganz, T. (2010). Detection, evaluation, and management of iron-restricted erythropoiesis. BLOOD, 116(23), 4754-4761.

Erythropoiesis stimulating agents, blood transfusion, and the practice of medicine
Goodnough, L. T., & Shander, A. S. (2010). Erythropoiesis stimulating agents, blood transfusion, and the practice of medicine. AMERICAN JOURNAL OF HEMATOLOGY, 85(11), 835-837.

Impact of cytomegalovirus (CMV) antibody reflex testing in the transfusion service on management of CMV-seronegative blood inventory
Fontaine, M. J., Jurado, C., Miller, E., Viele, M., & Goodnough, L. T. (2010). Impact of cytomegalovirus (CMV) antibody reflex testing in the transfusion service on management of CMV-seronegative blood inventory. TRANSFUSION, 50(8), 1685-1689.

Recombinant factor VIIa: an assessment of evidence regarding its efficacy and safety in the off-label setting.
Logan, A. C., & Goodnough, L. T. (2010). Recombinant factor VIIa: an assessment of evidence regarding its efficacy and safety in the off-label setting. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 2010, 153-159.

Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial
Van Wyck, D. B., Mangione, A., Morrison, J., Hadley, P. E., Jehle, J. A., & Goodnough, L. T. (2009). Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. TRANSFUSION, 49(12), 2719-2728.

The New Age of Iron: Evaluation and Management of Iron-Restricted Erythropoiesis
Goodnough, L. T. (2009). The New Age of Iron: Evaluation and Management of Iron-Restricted Erythropoiesis. SEMINARS IN HEMATOLOGY, 46(4), 325-327.

Retrospective analysis of transfusion outcomes in pregnant patients at a tertiary obstetric center
Butwick, A. J., Aleshi, P., Fontaine, M., Riley, E. T., & GOODNOUGH, L. T. (2009). Retrospective analysis of transfusion outcomes in pregnant patients at a tertiary obstetric center. INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA, 18(4), 302-308.

Improving platelet supply chains through collaborations between blood centers and transfusion services
Fontaine, M. J., Chung, Y. T., Rogers, W. M., Sussmann, H. D., Quach, P., & Erhun, F. (2009). Improving platelet supply chains through collaborations between blood centers and transfusion services. TRANSFUSION, 49(10), 2040-2047.

Implementation of a two-specimen requirement for verification of ABO/Rh for blood transfusion
Goodnough, L. T., Viele, M., Fontaine, M. J., Jurado, C., Stone, N., & Sharek, P. J. (2009). Implementation of a two-specimen requirement for verification of ABO/Rh for blood transfusion. TRANSFUSION, 49(7), 1321-1328.

A case of no pain and no gain from blood?
Shander, A., & Goodnough, L. T. (2009). A case of no pain and no gain from blood?. CRITICAL CARE MEDICINE, 37(6), 2104-2105.

Why an Alternative to Blood Transfusion?
Shander, A., & Goodnough, L. T. (2009). Why an Alternative to Blood Transfusion?. CRITICAL CARE CLINICS, 25(2), 261-?.

Iron overload and toxicity: the hidden risk of multiple blood transfusions
Shander, A., Cappellini, M. D., & GOODNOUGH, L. T. (2009). Iron overload and toxicity: the hidden risk of multiple blood transfusions. VOX SANGUINIS, 97(3), 185-197.

The role of intravenous iron in anemia management and transfusion avoidance
Auerbach, M., Goodnough, L. T., Picard, D., & Maniatis, A. (2008). The role of intravenous iron in anemia management and transfusion avoidance. TRANSFUSION, 48(5), 988-1000.

Impact of clinical trial design and execution-related factors on incidence of thromboembolic events in cancer patients: a systematic review and metaanalysis
Reynolds, M. W., Shibata, A., Zhao, S., Jones, N., Fahrbach, K., & Goodnough, L. T. (2008). Impact of clinical trial design and execution-related factors on incidence of thromboembolic events in cancer patients: a systematic review and metaanalysis. CURRENT MEDICAL RESEARCH AND OPINION, 24(2), 497-505.

Do preoperative anemia and polycythemia affect clinical outcome in patients undergoing major surgery?
Shander, A., & Goodnough, L. T. (2008). Do preoperative anemia and polycythemia affect clinical outcome in patients undergoing major surgery?. NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 5(1), 20-21.

Alloimmunization to red blood cell antigens affects clinical outcomes in liver transplant patients
Boyd, S. D., Stenard, F., Lee, D. Kk., Goodnough, L. T., Esquivel, C. O., & Fontaine, M. J. (2007). Alloimmunization to red blood cell antigens affects clinical outcomes in liver transplant patients. LIVER TRANSPLANTATION, 13(12), 1654-1661.

A randomized double-blind trial of hydroxychloroquine for the prevention of chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation
Fong, T., Trinkaus, A., Adkins, D., Vij, R., Devine, S. M., & Khoury, H. Y. (2007). A randomized double-blind trial of hydroxychloroquine for the prevention of chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 13(10), 1201-1206.

Transfusion triggers
Goodnough, L. T. (2007). Transfusion triggers. SURGERY, 142(4), S67-S70.

Recombinant factor VIIa: safety and efficacy
Goodnougha, L. T., & Shander, A. S. (2007). Recombinant factor VIIa: safety and efficacy. CURRENT OPINION IN HEMATOLOGY, 14(5), 504-509.

Update on transfusion medicine
Shander, A., & Goodnough, L. T. (2007). Update on transfusion medicine. PHARMACOTHERAPY, 27(9), 57S-68S.

How we treat: management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol
Burtelow, M., Riley, E., Druzin, M., Fontaine, M., Viele, M., & Goodnough, L. T. (2007). How we treat: management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol. TRANSFUSION, 47(9), 1564-1572.

Blood management
Goodnough, L. T., & Shander, A. (2007). Blood management. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 131(5), 695-701.

Erythropoietin and iron-restricted erythropoiesis
Goodnough, L. T. (2007). Erythropoietin and iron-restricted erythropoiesis. EXPERIMENTAL HEMATOLOGY, 35(4), 167-172.

Objectives and limitations of bloodless medical care
Shander, A., & Goodnough, L. T. (2006). Objectives and limitations of bloodless medical care. CURRENT OPINION IN HEMATOLOGY, 13(6), 462-470.

A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura
Mintz, P. D., Neff, A., MacKenzie, M., Goodnough, L. T., Hillyer, C., & Conlan, M. G. (2006). A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura. TRANSFUSION, 46(10), 1693-1704.

Anemia screening in elective surgery: Definition, significance and patients' interests
Shander, A., Javidroozi, M., & Goodnough, L. T. (2006). Anemia screening in elective surgery: Definition, significance and patients' interests. ANESTHESIA AND ANALGESIA, 103(3), 778-779.

Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: A systematic review of the literature
Ross, S. D., Allen, I. E., Henry, D. H., Seaman, C., Sercus, B., & Goodnough, L. T. (2006). Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: A systematic review of the literature. CLINICAL THERAPEUTICS, 28(6), 801-831.

Identification, diagnosis, and management of anemia in adult ambulatory patients treated by primary care physicians: evidence-based and consensus recommendations
Dubois, R. W., GOODNOUGH, L. T., Ershler, W. B., Van Winkle, L., & Nissenson, A. R. (2006). Identification, diagnosis, and management of anemia in adult ambulatory patients treated by primary care physicians: evidence-based and consensus recommendations. CURRENT MEDICAL RESEARCH AND OPINION, 22(2), 385-395.

Detection, evaluation, and management of anemia in the elective surgical patient
Goodnough, L. T., Shander, A., Spivak, J. L., Waters, J. H., Friedman, A. J., & Spence, R. (2005). Detection, evaluation, and management of anemia in the elective surgical patient. ANESTHESIA AND ANALGESIA, 101(6), 1858-1861.

Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone
Devine, S. M., Brown, R. A., Mathews, V., Trinkaus, K., Khoury, H., & DiPersio, J. F. (2005). Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone. BONE MARROW TRANSPLANTATION, 36(6), 531-538.

Autologous blood donation.
Goodnough, L. T. (2005). Autologous blood donation. Anesthesiology clinics of North America, 23(2), 263-?.

Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide
Girgis, M., Hallemeier, C., Blum, W., Brown, R., Lin, H. S., & Adkins, D. (2005). Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide. BLOOD, 105(8), 3035-3041.

Anemia of chronic disease.
Weiss, G., & Goodnough, L. T. (2005). Anemia of chronic disease. New England journal of medicine, 352(10), 1011-1023.

Evidence-based and consensus recommendations for the non-approved use of recombinant human factor VIIa therapy
Shander A, Goodnough LT, Ratko T, Matuszewski K, Cohn S, & Dubois R. (2005). Evidence-based and consensus recommendations for the non-approved use of recombinant human factor VIIa therapy. Pharmacotherapeutics, (30).

Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphoma
Hoerr, A. L., Gao, F., Hidalgo, J., Tiwari, D., Blum, K. A., & Khoury, H. J. (2004). Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphoma. JOURNAL OF CLINICAL ONCOLOGY, 22(22), 4561-4566.

Invited commentary.
Goodnough, L. T., & Shander, A. (2004). Invited commentary. Annals of thoracic surgery, 78(5), 1554-1555.

Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes
Hidalgo, J. D., Krone, R., Rich, M. W., Blum, K., Adkins, D., & Khoury, H. (2004). Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes. BONE MARROW TRANSPLANTATION, 34(7), 615-619.

Transfusion medicine service policies for recombinant factor VIIa administration
Goodnough, L. T., Lublin, D. M., Zhang, L., Despotis, G., & Eby, C. (2004). Transfusion medicine service policies for recombinant factor VIIa administration. TRANSFUSION, 44(9), 1325-1331.

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial
McCullough, J., Vesole, D. H., Benjamin, R. J., Slichter, S. J., Pineda, A., & Conlan, M. G. (2004). Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. BLOOD, 104(5), 1534-1541.

Blood and blood conservation: A national perspective
Goodnough, L. T. (2004). Blood and blood conservation: A national perspective. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 18(4), 6S-11S.

Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura
Zheng, X. L., Kaufman, R. M., GOODNOUGH, L. T., & Sadler, J. E. (2004). Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. BLOOD, 103(11), 4043-4049.

Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure and total body irradiation, cyclophosphamide, unrelated donor bone marrow transplants
Hallemeier, C., Girgis, M., Blum, W., Brown, R., Khoury, H., & Adkins, D. (2004). Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure and total body irradiation, cyclophosphamide, unrelated donor bone marrow transplants. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 10(5), 310-319.

Anemia and its clinical consequences in patients with chronic diseases.
Goodnough, L. T., & Nissenson, A. R. (2004). Anemia and its clinical consequences in patients with chronic diseases. American journal of medicine, 116, 1S-2S.

Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature.
Wilson, A., Yu, H.-T., Goodnough, L. T., & Nissenson, A. R. (2004). Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature. American journal of medicine, 116, 50S-57S.

Joint ASH and AABB educational session.
Goodnough, L. T., Hewitt, P. E., & Silliman, C. C. (2004). Joint ASH and AABB educational session. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 457-472.

Experiences with recombinant human factor VIIa in patients with thrombocytopenia
GOODNOUGH, L. T. (2004). Experiences with recombinant human factor VIIa in patients with thrombocytopenia. SEMINARS IN HEMATOLOGY, 41(1), 25-29.

Autoantibody formation after alloimmunization: are blood tranfusions a risk factor for autoimmune hemolytic anemia?
Young, P. P., Uzieblo, A., Trulock, E., Lublin, D. M., & Goodnough, L. T. (2004). Autoantibody formation after alloimmunization: are blood tranfusions a risk factor for autoimmune hemolytic anemia?. TRANSFUSION, 44(1), 67-72.

Risks of blood transfusion
Goodnough, L. T. (2003). Risks of blood transfusion. CRITICAL CARE MEDICINE, 31(12), S678-S686.

Hydroxychloroquine for the prevention of acute graft-versus-host disease after unrelated donor transplantation
Khoury, H., Trinkaus, K., Zhang, M. J., Adkins, D., Brown, R., & DiPersio, J. F. (2003). Hydroxychloroquine for the prevention of acute graft-versus-host disease after unrelated donor transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 9(11), 714-721.

Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicity
Chohan, R., Vij, R., Adkins, D., Blum, W., Brown, R., & Khoury, H. (2003). Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicity. BRITISH JOURNAL OF HAEMATOLOGY, 123(1), 110-113.

Low-dose short-course intravenous ganciclovir as pre-emptive therapy for CMV viremia post allo-PBSC transplantation
Vij, R., Khoury, H., Brown, R., GOODNOUGH, L. T., Devine, S. M., & DiPersio, J. F. (2003). Low-dose short-course intravenous ganciclovir as pre-emptive therapy for CMV viremia post allo-PBSC transplantation. BONE MARROW TRANSPLANTATION, 32(7), 703-707.

Patient safety and blood transfusion: New solutions
Dzik, W. H., Corwin, H., GOODNOUGH, L. T., Higgins, M., Kaplan, H., & Yomtovian, R. (2003). Patient safety and blood transfusion: New solutions. TRANSFUSION MEDICINE REVIEWS, 17(3), 169-180.

Anemia - Not just an innocent bystander?
Nissenson, A. R., GOODNOUGH, L. T., & Dubois, R. W. (2003). Anemia - Not just an innocent bystander?. ARCHIVES OF INTERNAL MEDICINE, 163(12), 1400-1404.

Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation
Linker, C., Anderlini, P., Herzig, R., Christiansen, N., Somlo, G., & Weaver, C. (2003). Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 9(6), 405-413.

Primary amyloidosis patients with significant organ dysfunction tolerate autologous transplantation after conditioning with single-dose total body irradiation alone: A feasibility study
Blum, W., Khoury, H., Lin, H. S., Vij, R., GOODNOUGH, L. T., & Adkins, D. (2003). Primary amyloidosis patients with significant organ dysfunction tolerate autologous transplantation after conditioning with single-dose total body irradiation alone: A feasibility study. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 9(6), 397-404.

Autologous blood procurement - acute normovolemic hemodilution vs. preoperative autologous blood donation
Goodnough, L. T. (2003). Autologous blood procurement - acute normovolemic hemodilution vs. preoperative autologous blood donation. ZENTRALBLATT FUR CHIRURGIE, 128(6), 462-467.

The use of erythropoietin to increase red cell mass
Goodnough, L. T. (2003). The use of erythropoietin to increase red cell mass. CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 50(6), S10-S18.

Bloodless medicine: clinical care without allogeneic blood transfusion
GOODNOUGH, L. T., Shander, A., & Spence, R. (2003). Bloodless medicine: clinical care without allogeneic blood transfusion. TRANSFUSION, 43(5), 668-676.

Transfusion medicine: looking to the future
GOODNOUGH, L. T., Shander, A., & Brecher, M. E. (2003). Transfusion medicine: looking to the future. LANCET, 361(9352), 161-169.

Evolution in alternatives to blood transfusion.
Goodnough, L. T., & Shander, A. (2003). Evolution in alternatives to blood transfusion. hematology journal , 4(2), 87-91.

The rise and fall of preoperative autologous blood donation (editorial). Transfusion. 2001;41:1459-62.
Brecher, M. E., & Goodnough, L. T. (2002). The rise and fall of preoperative autologous blood donation (editorial). Transfusion. 2001;41:1459-62. Transfusion, 42(12), 1618-1622.

Issues in the management of cancer-related thrombocytopenia
Goodnough, L. T., & Dipersio, J. Fd. (2002). Issues in the management of cancer-related thrombocytopenia. ONCOLOGY-NEW YORK, 16(11), 1558-1567.

Treatment of critical bleeding in the future intensive care unit
GOODNOUGH, L. T. (2002). Treatment of critical bleeding in the future intensive care unit. INTENSIVE CARE MEDICINE, 28, S221-S221.

Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII
Bui, J. D., Despotis, G. D., Trulock, E. P., PATTERSON, G. A., & Goodnough, L. T. (2002). Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 124(4), 852-854.

Indications for red cell transfusion
Goodnough, L. T. (2002). Indications for red cell transfusion. VOX SANGUINIS, 83, 7-9.

Acute normovolemic hemodilution
Goodnough, L. T. (2002). Acute normovolemic hemodilution. VOX SANGUINIS, 83, 211-215.

Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: Results of a randomized, double-blind trial
Levy, J. H., GOODNOUGH, L. T., Greilich, P. E., Parr, G. Vs., Stewart, R. W., & Vlahakes, G. J. (2002). Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: Results of a randomized, double-blind trial. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 124(1), 35-42.

Low-dose (550 cGy), single-exposure total body irradiation and cyclophosphamide: Consistent, durable engraftment of related-donor peripheral blood stem cells with low treatment-related mortality and fatal organ toxicity
Blum, W., Brown, R., Lin, H. S., Zehnbauer, B., Khoury, H., & Adkins, D. (2002). Low-dose (550 cGy), single-exposure total body irradiation and cyclophosphamide: Consistent, durable engraftment of related-donor peripheral blood stem cells with low treatment-related mortality and fatal organ toxicity. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 8(11), 608-618.

Anemia, transfusion, and mortality.
GOODNOUGH, L. T., & Bach, R. G. (2001). Anemia, transfusion, and mortality. NEW ENGLAND JOURNAL OF MEDICINE, 345(17), 1272-1274.

Thrombopoietin therapy increases platelet yields in healthy platelet donors
Kuter, D. J., GOODNOUGH, L. T., Romo, J., DiPersio, J., Peterson, R., & McCullough, J. (2001). Thrombopoietin therapy increases platelet yields in healthy platelet donors. BLOOD, 98(5), 1339-1345.

Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin
GOODNOUGH, L. T., Kuter, D. J., McCullough, J., Slichter, S. J., DiPersio, J., & Armstrong, S. (2001). Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin. BLOOD, 98(5), 1346-1351.

Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions
Uhlmann, E. J., Isgriggs, E., Wallhermfechtel, M., & Goodnough, L. T. (2001). Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions. TRANSFUSION, 41(8), 997-1000.

Transfusion medicine : support of patients undergoing cardiac surgery.
GOODNOUGH, L. T., & Despotis, G. J. (2001). Transfusion medicine : support of patients undergoing cardiac surgery. American journal of cardiovascular drugs , 1(5), 337-351.

Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy
Adkins, D. R., Abidi, M. H., Brown, R. A., Khoury, H., GOODNOUGH, L. T., & DiPersio, J. F. (2000). Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy. BONE MARROW TRANSPLANTATION, 26(11), 1239-1241.

The case against universal WBC reduction (and for the practice of evidence-based medicine)
Goodnough, L. T. (2000). The case against universal WBC reduction (and for the practice of evidence-based medicine). TRANSFUSION, 40(12), 1522-1527.

Management approaches to platelet-related microvascular bleeding in cardiothoracic surgery
Despotis, G. J., & GOODNOUGH, L. T. (2000). Management approaches to platelet-related microvascular bleeding in cardiothoracic surgery. ANNALS OF THORACIC SURGERY, 70(2), S20-S32.

Erythropoietin, iron, and erythropoiesis
Goodnough, L. T., Skikne, B., & Brugnara, C. (2000). Erythropoietin, iron, and erythropoiesis. BLOOD, 96(3), 823-833.

Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation
Adkins, D. R., GOODNOUGH, L. T., Shenoy, S., Brown, R., Moellering, J., & DiPersio, J. (2000). Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation. BLOOD, 95(11), 3605-3612.

Blood conservation in patients undergoing non-cardiac surgery.
Goodnough, L. T., & Monk, T. G. (2000). Blood conservation in patients undergoing non-cardiac surgery. Current opinion in anaesthesiology, 13(3), 365-370.

Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation
Khoury, H., Adkins, D., Brown, R., Vij, R., Westervelt, P., & DiPersio, J. F. (2000). Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation. BONE MARROW TRANSPLANTATION, 25(11), 1197-1201.

Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial
Brecher, M. E., & GOODNOUGH, L. T. (2000). Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial. TRANSFUSION, 40(3), 383-384.

Innovations in allogeneic stem-cell transplantation
DiPersio, J. F., Khoury, H., Haug, J., Vij, R., Adkins, D. R., & Brown, R. A. (2000). Innovations in allogeneic stem-cell transplantation. SEMINARS IN HEMATOLOGY, 37(1), 33-41.

What is a transfusion medicine specialist?
GOODNOUGH, L. T. (1999). What is a transfusion medicine specialist?. TRANSFUSION, 39(9), 1031-1033.

A prospective randomized comparison of three blood conservation strategies for radical prostatectomy
Monk, T. G., GOODNOUGH, L. T., Brecher, M. E., Colberg, J. W., Andriole, G. L., & Catalona, W. J. (1999). A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. ANESTHESIOLOGY, 91(1), 24-33.

Optimal management of bleeding and transfusion in patients undergoing cardiac surgery.
Despotis, G. J., Skubas, N. J., & GOODNOUGH, L. T. (1999). Optimal management of bleeding and transfusion in patients undergoing cardiac surgery. Seminars in thoracic and cardiovascular surgery, 11(2), 84-104.

The value of oxygen-carrying solutions in the operative setting, as determined by mathematical modeling
Brecher, M. E., GOODNOUGH, L. T., & Monk, T. (1999). The value of oxygen-carrying solutions in the operative setting, as determined by mathematical modeling. TRANSFUSION, 39(4), 396-402.

Where does preoperative erythropoietin therapy count? A mathematical perspective
Brecher, M. E., GOODNOUGH, L. T., & Monk, T. (1999). Where does preoperative erythropoietin therapy count? A mathematical perspective. TRANSFUSION, 39(4), 392-395.

Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: Graft-versus-host disease and transplant-related mortality
Brown, R. A., Adkins, D., Khoury, H., Vij, R., GOODNOUGH, L. T., & DiPersio, J. F. (1999). Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: Graft-versus-host disease and transplant-related mortality. JOURNAL OF CLINICAL ONCOLOGY, 17(3), 806-812.

Transfusion medicine. Second of two parts--blood conservation.
GOODNOUGH, L. T., Brecher, M. E., Kanter, M. H., & AUBUCHON, J. P. (1999). Transfusion medicine. Second of two parts--blood conservation. New England journal of medicine, 340(7), 525-533.

Transfusion medicine. First of two parts--blood transfusion.
GOODNOUGH, L. T., Brecher, M. E., Kanter, M. H., & AUBUCHON, J. P. (1999). Transfusion medicine. First of two parts--blood transfusion. New England journal of medicine, 340(6), 438-447.

A randomized trial of acute normovolemic hemodilution compared to preoperative autologous blood donation in total knee arthroplasty
Goodnough, L. T., Monk, T. G., Despotis, G. J., & Merkel, K. (1999). A randomized trial of acute normovolemic hemodilution compared to preoperative autologous blood donation in total knee arthroplasty. VOX SANGUINIS, 77(1), 11-16.

Economic impact of donor platelet count and platelet yield in apheresis products: Relevance for emerging issues in platelet transfusion therapy
Goodnough, L. T., Ali, S., Despotis, G., Dynis, M., & DiPersio, J. F. (1999). Economic impact of donor platelet count and platelet yield in apheresis products: Relevance for emerging issues in platelet transfusion therapy. VOX SANGUINIS, 76(1), 43-49.

Prevalence of HLA sensitization in female apheresis donors
Densmore, T. L., GOODNOUGH, L. T., Ali, S., Dynis, M., & Chaplin, H. (1999). Prevalence of HLA sensitization in female apheresis donors. TRANSFUSION, 39(1), 103-106.

Controversies in autologous blood procurement
GOODNOUGH, L. T. (1998). Controversies in autologous blood procurement. BRITISH JOURNAL OF ANAESTHESIA, 81, 67-72.

Oxygen carriers as blood substitutes - Past, present, and future
GOODNOUGH, L. T., Scott, M. G., & Monk, T. G. (1998). Oxygen carriers as blood substitutes - Past, present, and future. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, (357), 89-100.

Erythropoietin therapy in the perioperative setting
GOODNOUGH, L. T., & Monk, T. G. (1998). Erythropoietin therapy in the perioperative setting. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, (357), 82-88.

Acute normovolemic hemodilution
Monk, T. G., & GOODNOUGH, L. T. (1998). Acute normovolemic hemodilution. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, (357), 74-81.

Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy
Hogue, C. W., GOODNOUGH, L. T., & Monk, T. G. (1998). Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy. TRANSFUSION, 38(10), 924-931.

Guidelines for the treatment of preoperative anaemia with epoetin
Goodnough, L. T. (1998). Guidelines for the treatment of preoperative anaemia with epoetin. BIODRUGS, 10(3), 183-191.

The Collaborative Hospital Transfusion Study: variations in use of autologous blood account for hospital differences in red cell use during primary hip and knee surgery
Churchill, W. H., McGurk, S., Chapman, R. H., Wallace, E. L., Bertholf, M. F., & Surgenor, D. M. (1998). The Collaborative Hospital Transfusion Study: variations in use of autologous blood account for hospital differences in red cell use during primary hip and knee surgery. TRANSFUSION, 38(6), 530-539.

Compensatory erythropoiesis during routine autologous blood donation
GOODNOUGH, L. T., & Mercuriali, F. (1998). Compensatory erythropoiesis during routine autologous blood donation. TRANSFUSION, 38(6), 613-614.

Future directions in utilization review: The role of transfusion algorithms
Goodnough, L. T., & Despotis, G. J. (1998). Future directions in utilization review: The role of transfusion algorithms. TRANSFUSION SCIENCE, 19(1), 97-105.

The specific hospital significantly affects red cell and component transfusion practice in coronary artery bypass graft surgery: a study of five hospitals
Surgenor, D. M., Churchill, W. H., Wallace, E. L., Rizzo, R. J., McGurk, S., & Woodson, R. D. (1998). The specific hospital significantly affects red cell and component transfusion practice in coronary artery bypass graft surgery: a study of five hospitals. TRANSFUSION, 38(2), 122-134.

Erythropoiesis in patients stimulated with erythropoietin: The relevance of storage iron
GOODNOUGH, L. T., & Marcus, R. E. (1998). Erythropoiesis in patients stimulated with erythropoietin: The relevance of storage iron. VOX SANGUINIS, 75(2), 128-133.

Treatment of resistant mantle cell lymphoma with allogeneic bone marrow transplantation
Adkins, D., Brown, R., GOODNOUGH, L. T., Khoury, H., Popovic, W., & DiPersio, J. (1998). Treatment of resistant mantle cell lymphoma with allogeneic bone marrow transplantation. BONE MARROW TRANSPLANTATION, 21(1), 97-99.

Apheresis platelets: Emerging issues related to donor platelet count, apheresis platelet yield, and platelet transfusion dose
Goodnough, L. T., Kuter, D., McCullough, J., & Brecher, M. E. (1998). Apheresis platelets: Emerging issues related to donor platelet count, apheresis platelet yield, and platelet transfusion dose. JOURNAL OF CLINICAL APHERESIS, 13(3), 114-119.

Erythropoietin therapy in patients undergoing cardiac operations
Goodnough, L. T., Despotis, G. J., & Parvin, C. A. (1997). Erythropoietin therapy in patients undergoing cardiac operations. ANNALS OF THORACIC SURGERY, 64(6), 1579-1580.

Blood substitutes: evolution and future applications
Scott, M. G., Kucik, D. F., GOODNOUGH, L. T., & Monk, T. G. (1997). Blood substitutes: evolution and future applications. CLINICAL CHEMISTRY, 43(9), 1724-1731.

Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes
Despotis, G. J., Joist, J. H., & GOODNOUGH, L. T. (1997). Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes. CLINICAL CHEMISTRY, 43(9), 1684-1696.

Effect of hemoglobin- and Perflubron-based oxygen carriers on common clinical laboratory tests
Ma, Z. M., Monk, T. G., GOODNOUGH, L. T., McClellan, A., Gawryl, M., & Scott, M. G. (1997). Effect of hemoglobin- and Perflubron-based oxygen carriers on common clinical laboratory tests. CLINICAL CHEMISTRY, 43(9), 1732-1737.

Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies
Brown, R. A., Adkins, D., GOODNOUGH, L. T., Haug, J. S., Todd, G., & DiPersio, J. (1997). Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies. JOURNAL OF CLINICAL ONCOLOGY, 15(9), 3067-3074.

Relationship between leukocyte count and patient risk for excessive blood loss after cardiac surgery
Despotis, G. J., Levine, V., & GOODNOUGH, L. T. (1997). Relationship between leukocyte count and patient risk for excessive blood loss after cardiac surgery. CRITICAL CARE MEDICINE, 25(8), 1338-1346.

Whole blood heparin concentration measurements by automated protamine titration agree with plasma anti-Xa measurements
Despotis, G. J., Joist, J. H., GOODNOUGH, L. T., Santoro, S. A., & Spitznagel, E. (1997). Whole blood heparin concentration measurements by automated protamine titration agree with plasma anti-Xa measurements. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 113(3), 611-613.

Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients
Despotis, G. J., Levine, V., Filos, K. S., Santoro, S. A., Joist, J. H., & GOODNOUGH, L. T. (1996). Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients. ANESTHESIOLOGY, 85(6), 1311-1323.

More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather then ACT
Despotis, G. J., Joist, J. H., Hogue, C. W., ALSOUFIEV, A., JOINERMAIER, D., & GOODNOUGH, L. T. (1996). More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather then ACT. THROMBOSIS AND HAEMOSTASIS, 76(6), 902-908.

Utilization review for red cell transfusions - Are we just going through the motions?
GOODNOUGH, L. T., & Audet, A. M. (1996). Utilization review for red cell transfusions - Are we just going through the motions?. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 120(9), 802-803.

Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietin.
Price, T. H., GOODNOUGH, L. T., VOGLER, W. R., Sacher, R. A., HELLMAN, R. M., & Abels, R. I. (1996). Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietin. American journal of medicine, 101(2A), 22S-27S.

Evolving concepts in autologous blood procurement and transfusion: case reports of perisurgical anemia complicated by myocardial infarction.
GOODNOUGH, L. T., & Monk, T. G. (1996). Evolving concepts in autologous blood procurement and transfusion: case reports of perisurgical anemia complicated by myocardial infarction. American journal of medicine, 101(2A), 33S-37S.

Intraoperative salvage in patients undergoing elective abdominal aortic aneurysm repair: An analysis of cost and benefit
GOODNOUGH, L. T., Monk, T. G., Sicard, G., Satterfield, S. A., Allen, B., & Martin, K. (1996). Intraoperative salvage in patients undergoing elective abdominal aortic aneurysm repair: An analysis of cost and benefit. JOURNAL OF VASCULAR SURGERY, 24(2), 213-218.

Recurrent thrombosis of biventricular-support devices associated with accelerated intravascular coagulation and increased heparin requirements
Despotis, G. J., Levine, V., ALSOUFIEV, A., Joist, H., GOODNOUGH, L. T., & Pasque, M. (1996). Recurrent thrombosis of biventricular-support devices associated with accelerated intravascular coagulation and increased heparin requirements. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 112(2), 538-540.

Evaluation of complete blood count results from a new, on-site hemocytometer compared with a laboratory-based hemocytometer
Despotis, G. J., ALSOUFIEV, A., Hogue, C. W., Zoys, T. N., GOODNOUGH, L. T., & Lappas, D. G. (1996). Evaluation of complete blood count results from a new, on-site hemocytometer compared with a laboratory-based hemocytometer. CRITICAL CARE MEDICINE, 24(7), 1163-1167.

Determinants of red cell, platelet, plasma, and cryoprecipitate transfusions during coronary artery bypass graft surgery: The Collaborative Hospital Transfusion Study
Surgenor, D. M., Churchill, W. H., Wallace, E. L., Rizzo, R. J., Chapman, R. H., & Woodson, R. D. (1996). Determinants of red cell, platelet, plasma, and cryoprecipitate transfusions during coronary artery bypass graft surgery: The Collaborative Hospital Transfusion Study. TRANSFUSION, 36(6), 521-532.

Current red blood cell transfusion practices.
GOODNOUGH, L. T. (1996). Current red blood cell transfusion practices. AACN clinical issues, 7(2), 212-220.

Response of kaolin ACT to heparin: Evaluation with an automated assay and higher heparin doses
Despotis, G. J., ALSOUFIEV, A. L., Spitznagel, E., GOODNOUGH, L. T., & Lappas, D. G. (1996). Response of kaolin ACT to heparin: Evaluation with an automated assay and higher heparin doses. ANNALS OF THORACIC SURGERY, 61(3), 795-799.

Evaluating the appropriateness of red blood cell transfusions: The limitations of retrospective medical record reviews
Audet, A. M., GOODNOUGH, L. T., & Parvin, C. A. (1996). Evaluating the appropriateness of red blood cell transfusions: The limitations of retrospective medical record reviews. INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 8(1), 41-49.

Autologous blood procurement in the surgical setting: Lessons learned in the last 10 years
GOODNOUGH, L. T., Monk, T. G., & Brecher, M. E. (1996). Autologous blood procurement in the surgical setting: Lessons learned in the last 10 years. VOX SANGUINIS, 71(3), 133-141.

Stratifying patients preoperatively for transfusion outcomes
GOODNOUGH, L. T. (1996). Stratifying patients preoperatively for transfusion outcomes. ANNALS OF THORACIC SURGERY, 61(1), 8-9.

The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: A multicenter, randomized, double-blind, controlled trial
Price, T. H., GOODNOUGH, L. T., VOGLER, W. R., Sacher, R. A., HELLMAN, R. M., & Abels, R. I. (1996). The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: A multicenter, randomized, double-blind, controlled trial. TRANSFUSION, 36(1), 29-36.

Establishing practice guidelines for surgical blood management.
GOODNOUGH, L. T., & Despotis, G. J. (1995). Establishing practice guidelines for surgical blood management. American journal of surgery, 170(6A), 16S-20S.

Blood conservation strategies to minimize allogeneic blood use in urologic surgery.
Monk, T. G., & GOODNOUGH, L. T. (1995). Blood conservation strategies to minimize allogeneic blood use in urologic surgery. American journal of surgery, 170(6A), 69S-73S.

APROTININ PROLONGS WHOLE-BLOOD ACTIVATED PARTIAL THROMBOPLASTIN TIME BUT NOT WHOLE-BLOOD PROTHROMBIN TIME IN PATIENTS UNDERGOING CARDIAC-SURGERY
Despotis, G. J., ALSOUFIEV, A., GOODNOUGH, L. T., & Lappas, D. G. (1995). APROTININ PROLONGS WHOLE-BLOOD ACTIVATED PARTIAL THROMBOPLASTIN TIME BUT NOT WHOLE-BLOOD PROTHROMBIN TIME IN PATIENTS UNDERGOING CARDIAC-SURGERY. ANESTHESIA AND ANALGESIA, 81(5), 919-924.

ANTI-MAG ANTIBODY-ASSOCIATED POLYNEUROPATHIES - IMPROVEMENT FOLLOWING IMMUNOTHERAPY WITH MONTHLY PLASMA-EXCHANGE AND IV-CYCLOPHOSPHAMIDE
Blume, G., Pestronk, A., & GOODNOUGH, L. T. (1995). ANTI-MAG ANTIBODY-ASSOCIATED POLYNEUROPATHIES - IMPROVEMENT FOLLOWING IMMUNOTHERAPY WITH MONTHLY PLASMA-EXCHANGE AND IV-CYCLOPHOSPHAMIDE. NEUROLOGY, 45(8), 1577-1580.

ON THE NEED FOR IMPROVED TRANSFUSION INDICATORS IN CARDIAC-SURGERY
GOODNOUGH, L. T., Despotis, G. J., Hogue, C. W., & Ferguson, T. B. (1995). ON THE NEED FOR IMPROVED TRANSFUSION INDICATORS IN CARDIAC-SURGERY. ANNALS OF THORACIC SURGERY, 60(2), 473-480.

THE ENDOGENOUS ERYTHROPOIETIN RESPONSE AND THE ERYTHROPOIETIC RESPONSE TO BLOOD-LOSS ANEMIA - THE EFFECTS OF AGE AND GENDER
GOODNOUGH, L. T., Price, T. H., & Parvin, C. A. (1995). THE ENDOGENOUS ERYTHROPOIETIN RESPONSE AND THE ERYTHROPOIETIC RESPONSE TO BLOOD-LOSS ANEMIA - THE EFFECTS OF AGE AND GENDER. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 126(1), 57-64.

ACUTE NORMOVOLEMIC HEMODILUTION IS A COST-EFFECTIVE ALTERNATIVE TO PREOPERATIVE AUTOLOGOUS BLOOD DONATION BY PATIENTS UNDERGOING RADICAL RETROPUBIC PROSTATECTOMY
Monk, T. G., GOODNOUGH, L. T., Birkmeyer, J. D., Brecher, M. E., & Catalona, W. J. (1995). ACUTE NORMOVOLEMIC HEMODILUTION IS A COST-EFFECTIVE ALTERNATIVE TO PREOPERATIVE AUTOLOGOUS BLOOD DONATION BY PATIENTS UNDERGOING RADICAL RETROPUBIC PROSTATECTOMY. TRANSFUSION, 35(7), 559-565.

The relationship between hematocrit, blood lost, and blood transfused in total knee replacement. Implications for postoperative blood salvage and reinfusion.
GOODNOUGH, L. T., Verbrugge, D., & Marcus, R. E. (1995). The relationship between hematocrit, blood lost, and blood transfused in total knee replacement. Implications for postoperative blood salvage and reinfusion. The American journal of knee surgery, 8(3), 83-87.

The use of erythropoietin in the enhancement of autologous transfusion therapy.
GOODNOUGH, L. T. (1995). The use of erythropoietin in the enhancement of autologous transfusion therapy. Current opinion in hematology, 2(3), 214-218.

RECOMBINANT GROWTH-FACTORS
GOODNOUGH, L. T., & Anderson, K. C. (1995). RECOMBINANT GROWTH-FACTORS. TRANSFUSION SCIENCE, 16(1), 45-62.

EFFECT OF APROTININ ON ACTIVATED CLOTTING TIME, WHOLE-BLOOD AND PLASMA HEPARIN MEASUREMENTS
Despotis, G. J., Joist, J. H., JOINERMAIER, D., ALSOUFIEV, A. L., TRIANTAFILLOU, A. N., & Lappas, D. G. (1995). EFFECT OF APROTININ ON ACTIVATED CLOTTING TIME, WHOLE-BLOOD AND PLASMA HEPARIN MEASUREMENTS. ANNALS OF THORACIC SURGERY, 59(1), 106-111.

COMPARISON OF ACTIVATED COAGULATION LIME AND WHOLE-BLOOD HEPARIN MEASUREMENTS WITH LABORATORY PLASMA ANTI-XA HEPARIN CONCENTRATION IN PATIENTS HAVING CARDIAC OPERATIONS
Despotis, G. J., SUMMERFIELD, A. L., Joist, J. H., GOODNOUGH, L. T., Santoro, S. A., & Lappas, D. G. (1994). COMPARISON OF ACTIVATED COAGULATION LIME AND WHOLE-BLOOD HEPARIN MEASUREMENTS WITH LABORATORY PLASMA ANTI-XA HEPARIN CONCENTRATION IN PATIENTS HAVING CARDIAC OPERATIONS. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 108(6), 1076-1082.

The effect of recombinant human erythropoietin therapy on red cell expansion during autologous blood donation.
GOODNOUGH, L. T., & Marcus, R. E. (1994). The effect of recombinant human erythropoietin therapy on red cell expansion during autologous blood donation. Contemporary orthopaedics, 29(6), 430-434.

Role of hematopoietic growth factors in transfusion medicine.
GOODNOUGH, L. T. (1994). Role of hematopoietic growth factors in transfusion medicine. Current opinion in hematology, 1(6), 462-470.

DISTAL LOWER MOTOR-NEURON SYNDROME WITH HIGH-TITER SERUM IGM ANTI-GM(1) ANTIBODIES - IMPROVEMENT FOLLOWING IMMUNOTHERAPY WITH MONTHLY PLASMA-EXCHANGE AND INTRAVENOUS CYCLOPHOSPHAMIDE
Pestronk, A., Lopate, G., Kornberg, A. J., Elliott, J. L., Blume, G., & GOODNOUGH, L. T. (1994). DISTAL LOWER MOTOR-NEURON SYNDROME WITH HIGH-TITER SERUM IGM ANTI-GM(1) ANTIBODIES - IMPROVEMENT FOLLOWING IMMUNOTHERAPY WITH MONTHLY PLASMA-EXCHANGE AND INTRAVENOUS CYCLOPHOSPHAMIDE. NEUROLOGY, 44(11), 2027-2031.

CLINICAL-APPLICATION OF RECOMBINANT ERYTHROPOIETIN IN THE PERIOPERATIVE PERIOD
GOODNOUGH, L. T. (1994). CLINICAL-APPLICATION OF RECOMBINANT ERYTHROPOIETIN IN THE PERIOPERATIVE PERIOD. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 8(5), 1011-?.

IN-VITRO REVERSAL OF HEPARIN EFFECT WITH HEPARINASE - EVALUATION WITH WHOLE-BLOOD PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME IN CARDIAC SURGICAL PATIENTS
Despotis, G. J., SUMMERFIELD, A. L., Joist, J. H., GOODNOUGH, L. T., Santoro, S. A., & Lappas, D. G. (1994). IN-VITRO REVERSAL OF HEPARIN EFFECT WITH HEPARINASE - EVALUATION WITH WHOLE-BLOOD PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME IN CARDIAC SURGICAL PATIENTS. ANESTHESIA AND ANALGESIA, 79(4), 670-674.

ERYTHROPOIETIN RESPONSE TO ANEMIA IS NOT ALTERED BY SURGERY OR RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY
GOODNOUGH, L. T., Price, T. H., Parvin, C. A., Friedman, K. D., VOGLER, W. R., & Ciavarella, D. (1994). ERYTHROPOIETIN RESPONSE TO ANEMIA IS NOT ALTERED BY SURGERY OR RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY. BRITISH JOURNAL OF HAEMATOLOGY, 87(4), 695-699.

EFFICACY AND COST-EFFECTIVENESS OF AUTOLOGOUS BLOOD PREDEPOSIT IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY PROCEDURES
GOODNOUGH, L. T., GRISHABER, J. E., Birkmeyer, J. D., Monk, T. G., & Catalona, W. J. (1994). EFFICACY AND COST-EFFECTIVENESS OF AUTOLOGOUS BLOOD PREDEPOSIT IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY PROCEDURES. UROLOGY, 44(2), 226-231.

THE EFFECT OF PATIENT SIZE AND DOSE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY ON RED-BLOOD-CELL VOLUME EXPANSION IN AUTOLOGOUS BLOOD-DONORS FOR ELECTIVE ORTHOPEDIC OPERATION
GOODNOUGH, L. T., Verbrugge, D., Marcus, R. E., & Goldberg, V. (1994). THE EFFECT OF PATIENT SIZE AND DOSE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY ON RED-BLOOD-CELL VOLUME EXPANSION IN AUTOLOGOUS BLOOD-DONORS FOR ELECTIVE ORTHOPEDIC OPERATION. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 179(2), 171-176.

COST-EFFECTIVE STRATEGIES FOR AUTOLOGOUS BLOOD PROCUREMENT BEFORE SURGERY
GOODNOUGH, L. T. (1994). COST-EFFECTIVE STRATEGIES FOR AUTOLOGOUS BLOOD PROCUREMENT BEFORE SURGERY. VOX SANGUINIS, 67, 187-190.

THE SAFETY OF RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY IN AUTOLOGOUS BLOOD-DONORS
GOODNOUGH, L. T. (1994). THE SAFETY OF RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY IN AUTOLOGOUS BLOOD-DONORS. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 124(1), 17-18.

GUIDELINES FOR BLOOD UTILIZATION REVIEW
Stehling, L., LUBAN, N. Lc., Anderson, K. C., Sayers, M. H., Long, A., & HINES, D. M. (1994). GUIDELINES FOR BLOOD UTILIZATION REVIEW. TRANSFUSION, 34(5), 438-448.

ACUTE PREOPERATIVE HEMODILUTION IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY - A CASE-STUDY ANALYSIS OF EFFICACY
GOODNOUGH, L. T., GRISHABER, J. E., Monk, T. G., & Catalona, W. J. (1994). ACUTE PREOPERATIVE HEMODILUTION IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY - A CASE-STUDY ANALYSIS OF EFFICACY. ANESTHESIA AND ANALGESIA, 78(5), 932-937.

HAS RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY MINIMIZED RED-CELL TRANSFUSIONS IN HEMODIALYSIS-PATIENTS
GOODNOUGH, L. T., Strasburg, D., Riddell, J., Verbrugge, D., & Wish, J. (1994). HAS RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY MINIMIZED RED-CELL TRANSFUSIONS IN HEMODIALYSIS-PATIENTS. CLINICAL NEPHROLOGY, 41(5), 303-307.

THE EFFECT OF AN INTRAOPERATIVE TREATMENT ALGORITHM ON PHYSICIANS TRANSFUSION PRACTICE IN CARDIAC-SURGERY
Despotis, G. J., GRISHABER, J. E., & GOODNOUGH, L. T. (1994). THE EFFECT OF AN INTRAOPERATIVE TREATMENT ALGORITHM ON PHYSICIANS TRANSFUSION PRACTICE IN CARDIAC-SURGERY. TRANSFUSION, 34(4), 290-296.

THE IMPLICATIONS OF COST-EFFECTIVENESS FOR AUTOLOGOUS BLOOD PROCUREMENT
GOODNOUGH, L. T. (1994). THE IMPLICATIONS OF COST-EFFECTIVENESS FOR AUTOLOGOUS BLOOD PROCUREMENT. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 118(4), 333-334.

INFORMED CONSENT FOR BLOOD-TRANSFUSION AS A TRANSFUSION MEDICINE EDUCATIONAL INTERVENTION
GOODNOUGH, L. T., Hull, A. L., & Kleinhenz, M. E. (1994). INFORMED CONSENT FOR BLOOD-TRANSFUSION AS A TRANSFUSION MEDICINE EDUCATIONAL INTERVENTION. TRANSFUSION MEDICINE, 4(1), 51-55.

DISCHARGE HEMATOCRIT AS CLINICAL INDICATOR FOR BLOOD-TRANSFUSION AUDIT IN SURGERY PATIENTS
GOODNOUGH, L. T., VIZMEG, K., Riddell, J., & SOEGIARSO, R. W. (1994). DISCHARGE HEMATOCRIT AS CLINICAL INDICATOR FOR BLOOD-TRANSFUSION AUDIT IN SURGERY PATIENTS. TRANSFUSION MEDICINE, 4(1), 35-44.

THE IMPACT OF AUTOLOGOUS BLOOD ORDERING AND BLOOD PROCUREMENT PRACTICES ON ALLOGENEIC BLOOD EXPOSURE IN ELECTIVE ORTHOPEDIC-SURGERY PATIENTS
GOODNOUGH, L. T., VIZMEG, K., & Verbrugge, D. (1994). THE IMPACT OF AUTOLOGOUS BLOOD ORDERING AND BLOOD PROCUREMENT PRACTICES ON ALLOGENEIC BLOOD EXPOSURE IN ELECTIVE ORTHOPEDIC-SURGERY PATIENTS. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 101(3), 354-357.

THE EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN TREATMENT ON THE ENDURANCE PERFORMANCE OF SPRAGUE-DAWLEY RATS
VERBRUGGE, D. J., & GOODNOUGH, L. T. (1994). THE EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN TREATMENT ON THE ENDURANCE PERFORMANCE OF SPRAGUE-DAWLEY RATS. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 54(1), 55-59.

BACTERIAL-CONTAMINATION OF PLATELETS AT A UNIVERSITY HOSPITAL - INCREASED IDENTIFICATION DUE TO INTENSIFIED SURVEILLANCE
Zaza, S., Tokars, J. I., Yomtovian, R., Hirschler, N. V., Jacobs, M. R., & Jarvis, W. R. (1994). BACTERIAL-CONTAMINATION OF PLATELETS AT A UNIVERSITY HOSPITAL - INCREASED IDENTIFICATION DUE TO INTENSIFIED SURVEILLANCE. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 15(2), 82-87.

The use of growth factors as alternatives to blood products
Goodnough LT. (1994). The use of growth factors as alternatives to blood products. Transfusion Science.

COST-EFFECTIVENESS OF PREOPERATIVE AUTOLOGOUS DONATION IN CORONARY-ARTERY BYPASS-GRAFTING
Birkmeyer, J. D., AUBUCHON, J. P., LITTENBERG, B., OCONNOR, G. T., Nease, R. F., & GOODNOUGH, L. T. (1994). COST-EFFECTIVENESS OF PREOPERATIVE AUTOLOGOUS DONATION IN CORONARY-ARTERY BYPASS-GRAFTING. ANNALS OF THORACIC SURGERY, 57(1), 161-169.

Blood transfusion and blood conservation: cost and utilization issues.
GOODNOUGH, L. T., BODNER, M. S., & Martin, J. W. (1994). Blood transfusion and blood conservation: cost and utilization issues. American journal of medical quality , 9(4), 172-183.

A PHASE-III TRIAL OF RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY IN NONANEMIC ORTHOPEDIC PATIENTS SUBJECTED TO AGGRESSIVE REMOVAL OF BLOOD FOR AUTOLOGOUS USE - DOSE, RESPONSE, TOXICITY, AND EFFICACY
GOODNOUGH, L. T., Price, T. H., Friedman, K. D., Johnston, M., Ciavarella, D., & Abels, R. I. (1994). A PHASE-III TRIAL OF RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY IN NONANEMIC ORTHOPEDIC PATIENTS SUBJECTED TO AGGRESSIVE REMOVAL OF BLOOD FOR AUTOLOGOUS USE - DOSE, RESPONSE, TOXICITY, AND EFFICACY. TRANSFUSION, 34(1), 66-71.

Blood conservation and blood salvage
Goodnough LT, Bodner M, & Martin J. (1994). Blood conservation and blood salvage. J Int Care Med,.

INDICATIONS AND GUIDELINES FOR THE USE OF HEMATOPOIETIC GROWTH-FACTORS
GOODNOUGH, L. T., Anderson, K. C., Kurtz, S., Lane, T. A., Pisciotto, P. T., & Silberstein, L. E. (1993). INDICATIONS AND GUIDELINES FOR THE USE OF HEMATOPOIETIC GROWTH-FACTORS. TRANSFUSION, 33(11), 944-959.

A PROSPECTIVE MICROBIOLOGIC SURVEILLANCE PROGRAM TO DETECT AND PREVENT THE TRANSFUSION OF BACTERIALLY CONTAMINATED PLATELETS
Yomtovian, R., Lazarus, H. M., GOODNOUGH, L. T., Hirschler, N. V., Morrissey, A. M., & Jacobs, M. R. (1993). A PROSPECTIVE MICROBIOLOGIC SURVEILLANCE PROGRAM TO DETECT AND PREVENT THE TRANSFUSION OF BACTERIALLY CONTAMINATED PLATELETS. TRANSFUSION, 33(11), 902-909.

BLOOD LOST AND BLOOD TRANSFUSED IN CORONARY-ARTERY BYPASS GRAFT OPERATION AS IMPLICATIONS FOR BLOOD-TRANSFUSION AND BLOOD CONSERVATION STRATEGIES
GOODNOUGH, L. T., SOEGIARSO, R. W., & Geha, A. S. (1993). BLOOD LOST AND BLOOD TRANSFUSED IN CORONARY-ARTERY BYPASS GRAFT OPERATION AS IMPLICATIONS FOR BLOOD-TRANSFUSION AND BLOOD CONSERVATION STRATEGIES. SURGERY GYNECOLOGY & OBSTETRICS, 177(4), 345-351.

BLOOD CONSERVATION AND BLOOD-TRANSFUSION PRACTICES - FLIP SIDES OF THE SAME COIN
GOODNOUGH, L. T. (1993). BLOOD CONSERVATION AND BLOOD-TRANSFUSION PRACTICES - FLIP SIDES OF THE SAME COIN. ANNALS OF THORACIC SURGERY, 56(1), 3-4.

THE COST-EFFECTIVENESS OF PREOPERATIVE AUTOLOGOUS BLOOD DONATION FOR TOTAL HIP AND KNEE REPLACEMENT
Birkmeyer, J. D., GOODNOUGH, L. T., AUBUCHON, J. P., NOORDSIJ, P. G., & LITTENBERG, B. (1993). THE COST-EFFECTIVENESS OF PREOPERATIVE AUTOLOGOUS BLOOD DONATION FOR TOTAL HIP AND KNEE REPLACEMENT. TRANSFUSION, 33(7), 544-551.

Current trends: evolving concepts in transfusion medicine. The need for standardization of cryoprecipitate-derived fibrin adhesive.
Pisciotto, P. T., Anderson, K. C., GOODNOUGH, L. T., Kurtz, S. R., Lane, T. A., & Silberstein, L. E. (1993). Current trends: evolving concepts in transfusion medicine. The need for standardization of cryoprecipitate-derived fibrin adhesive. Transfusion science, 14(3), 291-294.

ECONOMIC-IMPACT OF INAPPROPRIATE BLOOD-TRANSFUSIONS IN CORONARY-ARTERY BYPASS GRAFT-SURGERY
GOODNOUGH, L. T., SOEGIARSO, R. W., Birkmeyer, J. D., & Welch, H. G. (1993). ECONOMIC-IMPACT OF INAPPROPRIATE BLOOD-TRANSFUSIONS IN CORONARY-ARTERY BYPASS GRAFT-SURGERY. AMERICAN JOURNAL OF MEDICINE, 94(5), 509-514.

BLOOD LOST AND TRANSFUSED IN PATIENTS UNDERGOING ELECTIVE ORTHOPEDIC OPERATION
GOODNOUGH, L. T., VIZMEG, K., & Marcus, R. E. (1993). BLOOD LOST AND TRANSFUSED IN PATIENTS UNDERGOING ELECTIVE ORTHOPEDIC OPERATION. SURGERY GYNECOLOGY & OBSTETRICS, 176(3), 235-238.

Blood transfusions in hip fracture patients: implications for blood conservation programs.
GOODNOUGH, L. T., Riddell, J., Verbrugge, D., & Marcus, R. E. (1993). Blood transfusions in hip fracture patients: implications for blood conservation programs. Journal of orthopaedic trauma, 7(1), 47-51.

Erythropoietin--does it increase the efficiency of autologous blood donation?
GOODNOUGH, L. T. (1993). Erythropoietin--does it increase the efficiency of autologous blood donation?. Beiträge zur Infusionstherapie = Contributions to infusion therapy, 29, 240-250.

Evaluating the safety and efficacy of pharmacologic alternatives to blood.
Goodnough LT. (1993). Evaluating the safety and efficacy of pharmacologic alternatives to blood. Ann Thor Surg, (56).

THE ROLE OF RECOMBINANT GROWTH-FACTORS IN TRANSFUSION MEDICINE
GOODNOUGH, L. T. (1993). THE ROLE OF RECOMBINANT GROWTH-FACTORS IN TRANSFUSION MEDICINE. BRITISH JOURNAL OF ANAESTHESIA, 70(1), 80-86.

The role of recombinant growth factors in transfusion medicine
Goodnough LT. (1993). The role of recombinant growth factors in transfusion medicine. Br J Anaesth,, (70).

PREVALENCE OF PLATELET TRANSFUSION REACTIONS BEFORE AND AFTER IMPLEMENTATION OF LEUKOCYTE-DEPLETED PLATELET CONCENTRATES BY FILTRATION
GOODNOUGH, L. T., Riddell, J., Lazarus, H., CHAFEL, T. L., Prince, G., & Yomtovian, R. (1993). PREVALENCE OF PLATELET TRANSFUSION REACTIONS BEFORE AND AFTER IMPLEMENTATION OF LEUKOCYTE-DEPLETED PLATELET CONCENTRATES BY FILTRATION. VOX SANGUINIS, 65(2), 103-107.

Blood conservation and blood transfusion practices: Flip sides of the same coin. Editorial.
Goodnough LT. (1993). Blood conservation and blood transfusion practices: Flip sides of the same coin. Editorial. Ann Thor Surg, (56).

The rationale for the use of recombinant human erythropoietin to facilitate autologous blood collection before elective surgery.
Goodnough LT. (1993). The rationale for the use of recombinant human erythropoietin to facilitate autologous blood collection before elective surgery. Contrib To Nephrol, (30).

IDENTIFYING ELECTIVE ORTHOPEDIC SURGICAL PATIENTS TRANSFUSED WITH AMOUNTS OF BLOOD IN EXCESS OF NEED - THE TRANSFUSION TRIGGER REVISITED
GOODNOUGH, L. T., Verbrugge, D., VIZMEG, K., & Riddell, J. (1992). IDENTIFYING ELECTIVE ORTHOPEDIC SURGICAL PATIENTS TRANSFUSED WITH AMOUNTS OF BLOOD IN EXCESS OF NEED - THE TRANSFUSION TRIGGER REVISITED. TRANSFUSION, 32(7), 648-653.

UTILIZATION AND EFFICACY OF AUTOLOGOUS BLOOD PREDEPOSIT IN RADICAL PROSTATECTOMY WITH LYMPHADENECTOMY - IMPLICATIONS FOR BLOOD CONSERVATION AND PHYSICIAN EDUCATION-PROGRAMS
GOODNOUGH, L. Tm., Riddell, J., Kursh, E., & Resnick, M. I. (1992). UTILIZATION AND EFFICACY OF AUTOLOGOUS BLOOD PREDEPOSIT IN RADICAL PROSTATECTOMY WITH LYMPHADENECTOMY - IMPLICATIONS FOR BLOOD CONSERVATION AND PHYSICIAN EDUCATION-PROGRAMS. UROLOGY, 40(3), 201-205.

LEUKOCYTE REDUCTION IN BLOOD COMPONENT THERAPY
Lane, T. A., Anderson, K. C., GOODNOUGH, L. T., Kurtz, S., MOROFF, G., & Silberstein, L. E. (1992). LEUKOCYTE REDUCTION IN BLOOD COMPONENT THERAPY. ANNALS OF INTERNAL MEDICINE, 117(2), 151-162.

SERUM ERYTHROPOIETIN LEVELS AND BLOOD COMPONENT THERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION - IMPLICATIONS FOR ERYTHROPOIETIN THERAPY IN THIS SETTING
Lazarus, H. M., GOODNOUGH, L. T., GOLDWASSER, E., Long, G., Arnold, J. L., & Strohl, K. P. (1992). SERUM ERYTHROPOIETIN LEVELS AND BLOOD COMPONENT THERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION - IMPLICATIONS FOR ERYTHROPOIETIN THERAPY IN THIS SETTING. BONE MARROW TRANSPLANTATION, 10(1), 71-75.

PREOPERATIVE RED-CELL PRODUCTION IN PATIENTS UNDERGOING AGGRESSIVE AUTOLOGOUS BLOOD PHLEBOTOMY WITH AND WITHOUT ERYTHROPOIETIN THERAPY
GOODNOUGH, L. T., Price, T. H., Rudnick, S., & SOEGIARSO, R. W. (1992). PREOPERATIVE RED-CELL PRODUCTION IN PATIENTS UNDERGOING AGGRESSIVE AUTOLOGOUS BLOOD PHLEBOTOMY WITH AND WITHOUT ERYTHROPOIETIN THERAPY. TRANSFUSION, 32(5), 441-445.

A PHASE-III RANDOMIZED STUDY COMPARING CISPLATIN AND FLUOROURACIL AS SINGLE AGENTS AND IN COMBINATION FOR ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
Jacobs, C., Lyman, G., VELEZGARCIA, E., Sridhar, K. S., Knight, W., & Rozencweig, M. (1992). A PHASE-III RANDOMIZED STUDY COMPARING CISPLATIN AND FLUOROURACIL AS SINGLE AGENTS AND IN COMBINATION FOR ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK. JOURNAL OF CLINICAL ONCOLOGY, 10(2), 257-263.

Prevalence and correlates of hospital-based autologous blood programs: a statewide survey.
Hull AL, Neuhauser DV, & Goodnough LT. (1992). Prevalence and correlates of hospital-based autologous blood programs: a statewide survey. Am J Med Sci., May;303(5).

Prudent strategies for elective red blood cell transfusion.
Welch HG, Meehan KR, & Goodnough LT. (1992). Prudent strategies for elective red blood cell transfusion. Ann Intern Med., Mar 1;116(5).

Teaching medical students concepts of informed consent within the framework of a transfusion medicine curriculum.
Goodnough LT, Hull AL, & Kleinhenz ME. (1992). Teaching medical students concepts of informed consent within the framework of a transfusion medicine curriculum. Acad Med., May;67(5).

Nonhemic prime in cardiopulmonary bypass. (reply to Letter).
Geha AS, & Goodnough LT. (1992). Nonhemic prime in cardiopulmonary bypass. (reply to Letter). Ann Thor Surg, (53).

Toward bloodless surgery: erythropoietin therapy in the surgical setting.
Goodnough LT. (1992). Toward bloodless surgery: erythropoietin therapy in the surgical setting. Semin Oncol., Jun;19(3 Suppl 8).

Designated blood requests in elective surgery (letter).
Goodnough LT, & Schuck JM. (1992). Designated blood requests in elective surgery (letter). Am J Surg, (163).

Autologous blood donation in nonorthopaedic surgical procedures as a blood conservation strategy.
Goodnough LT, Saha P, Hirschler NV, & Yomtovian R. (1992). Autologous blood donation in nonorthopaedic surgical procedures as a blood conservation strategy. Vox Sang., 63(2).

Strategies for elective red cell transfusion (reply to letter).
Goodnough LT, Welch HG, & Audet AM. (1992). Strategies for elective red cell transfusion (reply to letter). Ann Int Med, (117).

Erythropoietin therapy as a surgical blood conservation intervention.
Goodnough LT. (1992). Erythropoietin therapy as a surgical blood conservation intervention. Laboratory Medicine, (23).

Toward bloodless surgery: Erythropoietin in the surgical setting.
Goodnough LT. (1992). Toward bloodless surgery: Erythropoietin in the surgical setting. Seminars In Oncol.

Prevalence and classification of anemia in elective orthopedic surgery patients: implications for blood conservation programs.
Goodnough LT, Vizmeg K, Sobecks R, Schwarz A, & Soegiarso W. (1992). Prevalence and classification of anemia in elective orthopedic surgery patients: implications for blood conservation programs. Vox Sang., 63(2).

Reducing the risk for transfusion-transmitted cytomegalovirus infection.
Sayers MH, Anderson KC, Goodnough LT, Kurtz SR, Lane TA, & Silberstein LE. (1992). Reducing the risk for transfusion-transmitted cytomegalovirus infection. Ann Intern Med., Jan 1;116(1).

Effect of autologous blood donation in patients undergoing elective spine surgery.
Goodnough LT, & Marcus RE. (1992). Effect of autologous blood donation in patients undergoing elective spine surgery. Spine (Phila Pa 1976)., Feb;17(2).

Variation in blood component irradiation practice: implications for prevention of transfusion-associated graft-versus-host disease.
Anderson KC, Goodnough LT, Sayers M, Pisciotto PT, Kurtz SR, & Silberstein LE. (1991). Variation in blood component irradiation practice: implications for prevention of transfusion-associated graft-versus-host disease. Blood., May 15;77(10).

Selective in vivo removal of rheumatoid factor by an extracorporeal treatment device in rheumatoid arthritis patients.
Lazarus HM, Cohen SB, Clegg DO, Menitove JE, Sorin SB, & Fleischmann RM. (1991). Selective in vivo removal of rheumatoid factor by an extracorporeal treatment device in rheumatoid arthritis patients. Transfusion, Feb; 31(2).

The variability of transfusion practice in coronary artery bypass surgery. Transfusion Medicine Academic Award Group.
Goodnough LT, Johnston MF, & Toy PT. (1991). The variability of transfusion practice in coronary artery bypass surgery. Transfusion Medicine Academic Award Group. JAMA., Jan 2;265(1).

Iron-restricted erythropoiesis as a limitation to autologous blood donation in the erythropoietin-stimulated bone marrow.
Goodnough LT, Price TH, & Rudnick S. (1991). Iron-restricted erythropoiesis as a limitation to autologous blood donation in the erythropoietin-stimulated bone marrow. J Lab Clin Med., Sep;118(3).

A new era in blood conservation (editorial)
Goodnough LT, & Geha AS. (1991). A new era in blood conservation (editorial). Ann Thor Surg, (51).

Blood transfusion in elective orthopaedic surgery: Issues related to informed consent.
Goodnough LT, & Marcus RE. (1991). Blood transfusion in elective orthopaedic surgery: Issues related to informed consent. Perspectives in Orthopaedics, (2).

Autologous blood donation as a medical insurance policy (Letter)
Goodnough LT. (1990). Autologous blood donation as a medical insurance policy (Letter). Cont Obstet Gynec, (35).

Guidelines for transfusion support in patients undergoing coronary artery bypass grafting. Transfusion Practices Committee of the American Association of Blood Banks.
Goodnough LT, Johnston MF, Ramsey G, Sayers MH, Eisenstadt RS, & Silberstein LE. (1990). Guidelines for transfusion support in patients undergoing coronary artery bypass grafting. Transfusion Practices Committee of the American Association of Blood Banks. Ann Thorac Surg., Oct; 50(4).

Identifying personnel to receive continuing medical education about appropriate use of blood transfusions.
Goodnough LT, Hull AL, Brennan PF, Shah VA, & Martin B. (1990). Identifying personnel to receive continuing medical education about appropriate use of blood transfusions. Acad Med., Oct; 65(10).

Erythropoietin as a pharmacologic alternative to blood transfusion in the surgical patient.
Goodnough LT. (1990). Erythropoietin as a pharmacologic alternative to blood transfusion in the surgical patient. Transfus Med Rev., Oct; 4(4).

Erythropoietin as a pharmacologic alternative to homologous blood transfusion in the surgical patient
Goodnough LT. (1990). Erythropoietin as a pharmacologic alternative to homologous blood transfusion in the surgical patient. Transfusion Medicine Reviews, (4).

Recombinant human erythropoietin therapy in autologous blood donors
Goodnough LT. (1990). Recombinant human erythropoietin therapy in autologous blood donors. Progress In Clinical and Biological Research, (338).

Potential role of recombinant human erythropoietin in the peri-surgical setting.
Goodnough LT. (1990). Potential role of recombinant human erythropoietin in the peri-surgical setting. Int J Cell Cloning., Jan;8(Suppl 1).

"Homologous blood transfusion needs in elective orthopaedic surgery: Potential role of erythropoietin therapy. (Letter)
Goodnough LT, & Marcus RE. (1990). "Homologous blood transfusion needs in elective orthopaedic surgery: Potential role of erythropoietin therapy. (Letter). N Engl J Med, (322).

Utilization and effectiveness of autologous blood donation for arthroplastic surgery.
Goodnough LT, Shafron D, & Marcus RE. (1990). Utilization and effectiveness of autologous blood donation for arthroplastic surgery. Arthroplasty. 1990;5 Suppl:S89-94..

Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programs.
Goodnough LT, & Brittenham GM. (1990). Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programs. J Lab Clin Med., Jan;115(1).

The impact of preoperative autologous blood donation on orthopaedic surgical practice.
Goodnough LT, Shafron D, & Marcus RE. (1990). The impact of preoperative autologous blood donation on orthopaedic surgical practice. Vox Sang., 59(2).

Erythropoietin therapy in autologous blood donors.
Goodnough LT. (1990). Erythropoietin therapy in autologous blood donors. Prog Clin Biol Res., (338).

Risks, options, and informed consent for blood transfusion in elective surgery.
Goodnough LT, & Shuck JM. (1990). Risks, options, and informed consent for blood transfusion in elective surgery. Am J Surg. Review., Jun;159(6).

Directed blood procurement does not benefit patients who are enrolled in an autologous blood predeposit program.
Goodnough LT. (1989). Directed blood procurement does not benefit patients who are enrolled in an autologous blood predeposit program. Am J Clin Pathol., Oct; 92(4).

Red blood cell mass in autologous and homologous blood units. Implications for risk/benefit assessment of autologous blood crossover and directed blood transfusion.
Goodnough LT, Bravo JR, Hsueh YS, Keating LJ, & Brittenham GM. (1989). Red blood cell mass in autologous and homologous blood units. Implications for risk/benefit assessment of autologous blood crossover and directed blood transfusion. Transfusion., Nov-Dec;29(9).

Effects of a CME program on physicians' transfusion practices.
Hull AL, Wasman J, & Goodnough LT. (1989). Effects of a CME program on physicians' transfusion practices. Acad Med., Nov; 64(11).

A two-institution study of transfusion practice in 78 consecutive adult elective open-heart procedures.
Goodnough LT, Johnston MF, Shah T, & Chernosky A. (1989). A two-institution study of transfusion practice in 78 consecutive adult elective open-heart procedures. Am J Clin Pathol., Apr; 91(4).

Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy.
Goodnough LT, Rudnick S, Price TH, Ballas SK, Collins ML, & et al. (1989). Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med., Oct 26;321(17).

Limitations to donating adequate autologous blood prior to elective orthopedic surgery.
Goodnough LT, Wasman J, Corlucci K, & Chernosky A. (1989). Limitations to donating adequate autologous blood prior to elective orthopedic surgery. Arch Surg., Apr; 124(4).

The bleeding severity index: validation and comparison to other methods for classifying bleeding complications of medical therapy.
Landefeld CS, Anderson PA, Goodnough LT, Moir TW, Hom DL, & Goldman L. (1989). The bleeding severity index: validation and comparison to other methods for classifying bleeding complications of medical therapy. J Clin Epidemiol., 42(8).

Thrombogenic toxicity of breast cancer treatment: Chemotherapy versus antineoplastic effect. (Letter)
Goodnough LT, & Pearson O. (1988). Thrombogenic toxicity of breast cancer treatment: Chemotherapy versus antineoplastic effect. (Letter). N Engl J Med, (319).

Autologous blood donation. (Letter)
Goodnough LT. (1988). Autologous blood donation. (Letter). JAMA, (259).

Preleukemia in Fanconi's anemia: hematopoietic cell multinuclearity, membrane duplication, and dysgranulogenesis.
Barton JC, Parmley RT, Carroll AJ, Huang ST, Goodnough LT, & Ragab AH. (1987). Preleukemia in Fanconi's anemia: hematopoietic cell multinuclearity, membrane duplication, and dysgranulogenesis. J Submicrosc Cytol., Apr; 19(2).

Predeposited autologous blood for elective surgery. A national multicenter study.
Toy PT, Strauss RG, Stehling LC, Sears R, Price TH, & et al. (1987). Predeposited autologous blood for elective surgery. A national multicenter study. N Engl J Med., Feb 26;316(9).

Autologous blood donation for elective surgery. Effect on physician transfusion behavior.
Wasman J, & Goodnough LT. (1987). Autologous blood donation for elective surgery. Effect on physician transfusion behavior. JAMA., Dec 4;258(21).

Reptilase time for ANLL with DIC. (letter)
Spitzer T, Rosenzweig SE, Goodnough LT, Lazarus HM, & Herzig RH. (1986). Reptilase time for ANLL with DIC. (letter). Sca nd J Haematol, (36).

Histidine-rich glycoprotein and changes in the components of the fibrinolytic system after streptokinase therapy in patients with pulmonary thromboembolism.
Goodnough LT, Saito H, Bell WR, & Heimburger N. (1985). Histidine-rich glycoprotein and changes in the components of the fibrinolytic system after streptokinase therapy in patients with pulmonary thromboembolism. Am J Hematol., Jul; 19(3).

Bovine aortic endothelial cells elaborate an inhibitor of the generation of lipopolysaccharide-stimulated human blood monocyte procoagulant activity.
Goodnough LT, Kleinhenz ME, Goldsmith GH Jr, Ziats NP, & Robertson AL Jr. (1984). Bovine aortic endothelial cells elaborate an inhibitor of the generation of lipopolysaccharide-stimulated human blood monocyte procoagulant activity. J Clin Invest., Jul;74(1).

Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients.
Goodnough LT, Saito H, Manni A, Jones PK, & Pearson OH. (1984). Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients. Cancer., Oct 1; 54(7).

Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases.
Goodnough LT, Saito H, & Ratnoff OD. (1983). Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases. Medicine (Baltimore)., Jul; 62(4).

Synthesis and release of Hageman factor (Factor XII) by the isolated perfused rat liver.
Saito H, Hamilton SM, Tavill AS, Goodnough LT, Louis L, & Angell A. (1983). Synthesis and release of Hageman factor (Factor XII) by the isolated perfused rat liver. J Clin Invest., Sep;72(3).

Fibronectin levels in congenital thrombocytopenia: Schulman's syndrome. (letter)
Goodnough LT, Saito H, & Ratnoff OD. (1982). Fibronectin levels in congenital thrombocytopenia: Schulman's syndrome. (letter). N Engl J Med, (306).

Specific binding of thrombin by human peripheral blood monocytes: possible role in the clearance of activated clotting factors from the circulation.
Goodnough LT, & Saito H. (1982). Specific binding of thrombin by human peripheral blood monocytes: possible role in the clearance of activated clotting factors from the circulation. J Lab Clin Med., Jun;99(6).

Synthesis and secretion of alpha 2-plasmin inhibitor by established human liver cell lines.
Saito H, Goodnough LT, Knowles BB, & Aden DP. (1982). Synthesis and secretion of alpha 2-plasmin inhibitor by established human liver cell lines. Proc Natl Acad Sci U S A., Sep; 79(18).

Reduced histidine-rich glycoprotein levels in plasma of patients with advanced liver cirrhosis. Possible implications for enhanced fibrinolysis.
Saito H, Goodnough LT, Boyle JM, & Heimburger N. (1982). Reduced histidine-rich glycoprotein levels in plasma of patients with advanced liver cirrhosis. Possible implications for enhanced fibrinolysis. Am J Med., Aug; 73(2).

Urinary excretion of Hageman factor (factor XII) and the presence of nonfunctional Hageman factor in the nephrotic syndrome.
Saito H, Goodnough LT, Makker SP, & Kallen RJ. (1981). Urinary excretion of Hageman factor (factor XII) and the presence of nonfunctional Hageman factor in the nephrotic syndrome. Am J Med., 70(3).

Heterogeneity of human prekallikrein deficiency (Fletcher trait): evidence that five of 18 cases are positive for cross-reacting material.
Saito H, Goodnough LT, Soria J, Soria C, Aznar J, & España F. (1981). Heterogeneity of human prekallikrein deficiency (Fletcher trait): evidence that five of 18 cases are positive for cross-reacting material. N Engl J Med., Oct 15;305(16).

Bullous pemphigoid as a manifestation of chronic lymphocytic leukemia.
Goodnough LT, & Muir WA. (1980). Bullous pemphigoid as a manifestation of chronic lymphocytic leukemia. Arch Intern Med., 140(11).